Hemmingsen, J.K.; Enemark, M.H.; Sørensen, E.F.; Lauridsen, K.L.; Hamilton-Dutoit, S.J.; Kridel, R.; Honoré, B.; Ludvigsen, M.
Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma. Cancers 2024, 16, 3278.
https://doi.org/10.3390/cancers16193278
AMA Style
Hemmingsen JK, Enemark MH, Sørensen EF, Lauridsen KL, Hamilton-Dutoit SJ, Kridel R, Honoré B, Ludvigsen M.
Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma. Cancers. 2024; 16(19):3278.
https://doi.org/10.3390/cancers16193278
Chicago/Turabian Style
Hemmingsen, Jonas Klejs, Marie Hairing Enemark, Emma Frasez Sørensen, Kristina Lystlund Lauridsen, Stephen Jacques Hamilton-Dutoit, Robert Kridel, Bent Honoré, and Maja Ludvigsen.
2024. "Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma" Cancers 16, no. 19: 3278.
https://doi.org/10.3390/cancers16193278
APA Style
Hemmingsen, J. K., Enemark, M. H., Sørensen, E. F., Lauridsen, K. L., Hamilton-Dutoit, S. J., Kridel, R., Honoré, B., & Ludvigsen, M.
(2024). Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma. Cancers, 16(19), 3278.
https://doi.org/10.3390/cancers16193278